ApprovalTrail

Approval · Notice of Compliance 21506 · 2018

EXPERIOR: Notice of Compliance 21506

Issued November 7, 2018

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
21506
Date
November 7, 2018
Company
Elanco Canada LimitedGuelph, Ontario, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other

Products in this notice

BrandDINStatus today
EXPERIOR02482061Marketed

Medicinal ingredients